BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Chackelevicius CM, Gambaro SE, Tiribelli C, Rosso N. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. World J Gastroenterol 2016; 22(41): 9096-9103 [PMID: 27895397 DOI: 10.3748/wjg.v22.i41.9096]
URL: https://www.wjgnet.com/1007-9327/full/v22/i41/9096.htm
(358) (443) (0) (0) (11246) (52)
Number Citing Articles
1
Yinan Zhao, Yige Wang, Faying Li, Guoying Yu. Hypoxia-inducible factors in the immunometabolism of metabolic dysfunction-associated steatotic liver disease (MASLD): molecular mechanisms and therapeutic implications. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1779019
2
Chuheng Gou, Wenjie Zhang, Hao Xu, Hong Zhang, Rui Ding, Xuan Zhang. Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage. iLIVER 2025; 4(4) doi: 10.1016/j.iliver.2025.100195
3
Paolo Gisondi, Francesco Bellinato, Manfredo Bruni, Giulia De Angelis, Giampiero Girolomoni. Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome. Dermatologic Therapy 2020; 33(6) doi: 10.1111/dth.14281
4
Haiyan Zhou, Liwen Wang, Feng Liu. Immunological Impact of Intestinal T Cells on Metabolic Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.639902
5
Z. Yao, G. Liang, Z. L. Lv, L. C. Lan, F. L. Zhu, Q. Tang, L. Huang, X. Q. Chen, M. X. Yang, Q. W. Shan. Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β. Bulletin of Experimental Biology and Medicine 2021; 171(5) doi: 10.1007/s10517-021-05285-2
6
Hua Zhang, Yongyuan Ma, Xinying Cheng, Dongbo Wu, Xingming Huang, Bin Chen, Yafeng Ren, Wei Jiang, Xiaoqiang Tang, Ting Bai, Yutian Chen, Yilin Zhao, Chunxue Zhang, Xia Xiao, Jing Liu, Yue Deng, Tinghong Ye, Lu Chen, Han-Min Liu, Scott L. Friedman, Liping Chen, Bi-Sen Ding, Zhongwei Cao. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine 2021; 13(614) doi: 10.1126/scitranslmed.abd1206
7
Kristine Griffett, Matthew E. Hayes, Michael P. Boeckman, Thomas P. Burris. The role of REV-ERB in NASH. Acta Pharmacologica Sinica 2022; 43(5) doi: 10.1038/s41401-022-00883-w
8
Gabriel P. Bacil, Bruno Cogliati, Daniel R. Cardoso, Luís Fernando Barbisan, Guilherme R. Romualdo. Are isothiocyanates and polyphenols from Brassicaceae vegetables emerging as preventive/therapeutic strategies for NAFLD? The landscape of recent preclinical findings. Food & Function 2022; 13(16) doi: 10.1039/D2FO01488B
9
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
10
Shuhui Tan, Mingyue Liu, Fei Feng, Ruicheng Li, Rui Tian, Zhenhua Nie, Seth Agyei Domfeh. Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD. PLOS ONE 2024; 19(6) doi: 10.1371/journal.pone.0305217
11
Tao Hao, Hongying Chen, Sisi Wu, Haoming Tian. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. Molecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10304
12
Cecilia Pessoa Rodrigues, Aindrila Chatterjee, Meike Wiese, Thomas Stehle, Witold Szymanski, Maria Shvedunova, Asifa Akhtar. Histone H4 lysine 16 acetylation controls central carbon metabolism and diet-induced obesity in mice. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26277-w
13
Tiziano Balzano, Jerónimo Forteza, Pilar Molina, Juan Giner, Ana Monzó, Jennifer Sancho-Jiménez, Amparo Urios, Carmina Montoliu, Vicente Felipo. The Cerebellum of Patients with Steatohepatitis Shows Lymphocyte Infiltration, Microglial Activation and Loss of Purkinje and Granular Neurons. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21399-6
14
Carlo Smirne, Violante Mulas, Matteo Nazzareno Barbaglia, Venkata Ramana Mallela, Rosalba Minisini, Nadia Barizzone, Michela Emma Burlone, Mario Pirisi, Elena Grossini. Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease. Diagnostics 2020; 10(12) doi: 10.3390/diagnostics10121003
15
Kirsten I M Looman, Susana Santos, Henriette A Moll, Charlotte W E Leijten, Christina Grosserichter-Wagener, Trudy Voortman, Vincent V W Jaddoe, Menno C van Zelm, Jessica C Kiefte-de Jong. Childhood Adiposity Associated With Expanded Effector Memory CD8+ and Vδ2+Vγ9+ T Cells. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10) doi: 10.1210/clinem/dgab433
16
Anzhu Wang, Zhendong Li, Zhuo Sun, Yifei Wang, Shuangqing Fu, Dawu Zhang, Xiaochang Ma. Heart Failure with Preserved Ejection Fraction and Non-Alcoholic Fatty Liver Disease: New Insights from Bioinformatics. ESC Heart Failure 2023; 10(1) doi: 10.1002/ehf2.14211
17
Jeffrey B. Schwimmer, Jethro S. Johnson, Jorge E. Angeles, Cynthia Behling, Patricia H. Belt, Ingrid Borecki, Craig Bross, Janis Durelle, Nidhi P. Goyal, Gavin Hamilton, Mary L. Holtz, Joel E. Lavine, Makedonka Mitreva, Kimberly P. Newton, Amy Pan, Pippa M. Simpson, Claude B. Sirlin, Erica Sodergren, Rahul Tyagi, Katherine P. Yates, George M. Weinstock, Nita H. Salzman. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019; 157(4) doi: 10.1053/j.gastro.2019.06.028
18
E González-Reimers, C Martín-González, G Quintero-Platt, L Romero-Acevedo, O Pérez-Hernández. Relative and combined Effects of Ethanol and Hepatitis C Virus Infection on Serum Interleukin-17 Levels. Archives of Hepatitis Research 2017; 3(1) doi: 10.17352/ahr.000010
19
Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal-Gonzalez, Magalie Boucher, Dinesh Hirenallur-Shanthappa, Jeffrey Morin, Alan C. Opsahl, Sarah R. Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler. Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(4) doi: 10.1016/j.jcmgh.2020.06.001
20
Wenjing Gou, Di Zhang, Lianyin Gao. Qingdu decoction can reduce LPS induced ACLF endotoxemia by regulating microRNA-34c/MAZ/TJs and microRNA-122a/Zonulin/EGFR signal pathway. Journal of Ethnopharmacology 2023; 302 doi: 10.1016/j.jep.2022.115922
21
ChuHan Ma, Shuyue Wang, Bingning Dong, Yu Tian. Metabolic reprogramming of immune cells in MASH. Hepatology 2025;  doi: 10.1097/HEP.0000000000001371
22
Yutian Zhang, Lang Liu, Ruihao Song, Ziyi Qu, Tianlin Wang, Lei Liang, Shunhua Wang, Shuzhi Zhang, Huizhen Li, Hong Wang. Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1653372
23
Haoran Xie, Junjun Wang, Qiuyan Zhao. Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-86397-x
24
Mengxuan Hao, Zihui Wang, Liren Wang, Aidiya Yimamu, Xiaoling Su, Minmin Zhang, Xincan Li, Quanlong Zhang, Zeyu Sun. Flavonoids as modulators of gut-liver axis: emerging therapeutic strategies for MAFLD. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1657751
25
Wei Qiang Chng, Jake J. Liew, Choon Fong Liew, Mark Muthiah, Ming-Hua Zheng, Hazel H. Oon. Hidradenitis suppurativa and psoriasis: shared immunological links with metabolic-associated steatotic liver disease. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1831174
26
Alessandra Fiorillo, Juan-José Gallego, Franc Casanova-Ferrer, Carla Giménez-Garzó, Amparo Urios, Maria-Pilar Ballester, Lucia Durbán, Maria-Pilar Rios, Javier Megías, Teresa San Miguel, Elena Kosenko, Desamparados Escudero-García, Salvador Benlloch, Vicente Felipo, Carmina Montoliu. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210407
27
Piero Portincasa, Mohamad Khalil, Annarita Graziani, Gema Frühbeck, Gyorgy Baffy, Gabriella Garruti, Agostino Di Ciaula, Leonilde Bonfrate. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?. European Journal of Internal Medicine 2024; 119 doi: 10.1016/j.ejim.2023.10.002
28
Mohamed E. Shaker, Mohamed F. Hamed, Ahmed A. Shaaban. Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. Saudi Pharmaceutical Journal 2022; 30(3) doi: 10.1016/j.jsps.2022.01.007
29
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124 doi: 10.1016/j.yexmp.2021.104733
30
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez, Senad Divanovic. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 2023; 35(11) doi: 10.1016/j.cmet.2023.10.009
31
Zheng Luo, Cong Huang, Jilan Chen, Yunhui Chen, Hongya Yang, Qiaofeng Wu, Fating Lu, Tian E. Zhang. Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1323859
32
Ilias D. Vachliotis, Stergios A. Polyzos. The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00657-5
33
Chun-Pyo Hong, Areum Park, Bo-Gie Yang, Chang Ho Yun, Min-Jung Kwak, Gil-Woo Lee, Jung-Hwan Kim, Min Seong Jang, Eun-Jung Lee, Eun-Ji Jeun, Gihoon You, Kwang Soon Kim, Youngwoo Choi, Ji-Hwan Park, Daehee Hwang, Sin-Hyeog Im, Jihyun F. Kim, Yoon-Keun Kim, Ju-Young Seoh, Charles D. Surh, You-Me Kim, Myoung Ho Jang. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice. Gastroenterology 2017; 152(8) doi: 10.1053/j.gastro.2017.02.016
34
Denis Nchang Che, Jae Young Shin, Hyun Ju Kang, Byoung Ok Cho, Ji Hyeon Park, Feng Wang, Suping Hao, Jae Suk Sim, Dong Jun Sim, Seon Il Jang. Ameliorative effects of Cirsium japonicum extract and main component cirsimaritin in mice model of high‐fat diet‐induced metabolic dysfunction‐associated fatty liver disease. Food Science & Nutrition 2021; 9(11) doi: 10.1002/fsn3.2548
35
Changyan Zi, Die Wang, Yongxiang Gao, Lisha He. The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1104943
36
Audrey Beringer, Pierre Miossec. Systemic effects of IL-17 in inflammatory arthritis. Nature Reviews Rheumatology 2019; 15(8) doi: 10.1038/s41584-019-0243-5
37
Zheng Luo, Lu-Yun Xia, Yu-Qin Tang, Lili Huang, Dan Liu, Wen-Ying Huai, Chun-Jiang Zhang, Yan-Qiu Wang, Yong-Mei Xie, Qiao-Zhi Yin, Yun-Hui Chen, Tian-E. Zhang, Robson Xavier Faria. Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/1670014
38
Kung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, Yu-De Chu, Chih-Lang Lin, Wey-Ran Lin, Ya-Hui Huang, Tong-Hung Wang, Rong-Nan Chien, Tsung-Hui Hu, Chau-Ting Yeh. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01761-1
39
Bahram Namjou, Todd Lingren, Yongbo Huang, Sreeja Parameswaran, Beth L. Cobb, Ian B. Stanaway, John J. Connolly, Frank D. Mentch, Barbara Benoit, Xinnan Niu, Wei-Qi Wei, Robert J. Carroll, Jennifer A. Pacheco, Isaac T. W. Harley, Senad Divanovic, David S. Carrell, Eric B. Larson, David J. Carey, Shefali Verma, Marylyn D. Ritchie, Ali G. Gharavi, Shawn Murphy, Marc S. Williams, David R. Crosslin, Gail P. Jarvik, Iftikhar J. Kullo, Hakon Hakonarson, Rongling Li, Stavra A. Xanthakos, John B. Harley. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. BMC Medicine 2019; 17(1) doi: 10.1186/s12916-019-1364-z
40
George Papadopoulos, Robert Berland, Ashwini Sunkavalli, Stephen R. Coats, Richard P. Darveau, Caroline A. Genco, Marvin Whiteley. Microbial Lipid A Remodeling Controls Cross-Presentation Efficiency and CD8 T Cell Priming by Modulating Dendritic Cell Function. Infection and Immunity 2021; 89(2) doi: 10.1128/IAI.00335-20
41
E. L. Nasonov, T. V. Korotaeva, T. V. Dubinina, A. M. Lila. IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS. Rheumatology Science and Practice 2019; 57(4) doi: 10.14412/1995-4484-2019-400-406
42
Claire E. McQuitty, Roger Williams, Shilpa Chokshi, Luca Urbani. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.574276
43
Suling Zeng, Bernd Schnabl. Roles for the mycobiome in liver disease. Liver International 2022; 42(4) doi: 10.1111/liv.15160
44
Yan Jia, Fenmiao Zhong, Shuoyi Jiang, Qin Guo, Huanhuan Jin, Feixia Wang, Mengmeng Li, Ling Wang, Anping Chen, Feng Zhang, Jiangjuan Shao, Shizhong Zheng. Periostin in chronic liver diseases: Current research and future perspectives. Life Sciences 2019; 226 doi: 10.1016/j.lfs.2019.04.021
45
Ioannis Tsomidis, Angeliki Tsakou, Argyro Voumvouraki, Elias Kouroumalis. The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010151
46
M. Gulubova, M. Hadzhi, L. Hadzhiilieva, D. Chonov, M. M. Ignatova. Dendritic Cells and T Cell Subsets in the Development of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Acta Medica Bulgarica 2021; 48(3) doi: 10.2478/amb-2021-0037
47
Mario Romeo, Alessia Silvestrin, Giusy Senese, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Annachiara Coppola, Pierluigi Federico, Marcello Dallio, Alessandro Federico. From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomedicines 2025; 13(8) doi: 10.3390/biomedicines13082004
48
Branka Filipovic, Snezana Lukic, Dragana Mijac, Marija Marjanovic-Haljilji, Marko Vojnovic, Jelena Bogdanovic, Tijana Glisic, Natasa Filipovic, Jamal Al Kiswani, Aleksandra Djokovic, Suncica Kapor, Slobodan Kapor, Zoran Bukumiric, Ana Starcevic. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(24) doi: 10.3390/ijms222413219
49
Lichen Bao, Jun Yin, Wen Gao, Qun Wang, Wenbing Yao, Xiangdong Gao. A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway. British Journal of Pharmacology 2018; 175(16) doi: 10.1111/bph.14383
50
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
51
Giuseppina Vizioli, Alberto Nicoletti, Daniela Feliciani, Barbara Funaro, Lorenzo Zileri Dal Verme, Francesca Romana Ponziani, Maria Assunta Zocco, Antonio Gasbarrini, Maurizio Gabrielli. Immunotherapy and MASLD-Related HCC: Should We Reconsider the Role of Etiology in the Therapeutic Approach to HCC?. Applied Sciences 2025; 15(5) doi: 10.3390/app15052279
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.